Non-Hodgkin's Lymphoma, Phase I

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

Volunteers
Health Professionals

What is the purpose of this trial?

This study will investigate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ONO-4685 in patients with relapsed or refractory T cell Lymphoma

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Daniel Moncayo

daniel.moncayo@yale.edu

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Francine Foss, MD
Professor of Medicine (Hematology) and of Dermatology; Director, Multidisciplinary T cell Lymphoma Program, Hematology; Scientific Leader, Lymphoma CRT, Yale Cancer Center

Sub-Investigators

Last Updated
03/28/2025
Study HIC
#2000037506